FDA Panel Recommends the First Over-the-Counter Birth Control Pill.

The article discusses a recent unanimous recommendation by a U.S. Food and Drug Administration (FDA) expert panel to make the oral contraceptive pill Opill available over-the-counter, marking a significant development in women's reproductive health. This recommendation comes amid ongoing challenges to reproductive rights in the U.S., including new abortion bans and legal uncertainties surrounding the abortion pill mifepristone. While the panel expressed concerns about the validity of some data provided by Opill's manufacturer, HRA Pharma Perrigo, they ultimately concluded that the benefits of increased access to contraception and the potential reduction in unintended pregnancies outweighed the risks of unsupervised use. The final decision on the recommendation will be made by the FDA commissioner. [Extracted from the article]